Status:
COMPLETED
Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment
Lead Sponsor:
Meir Medical Center
Conditions:
Ovarian Stimulation
Eligibility:
FEMALE
18-42 years
Phase:
NA
Brief Summary
The aim of this study was to evaluate the effect of dehydroepiandrosterone supplementation on in vitro fertilization performance and outcome among poor-responder patient.
Eligibility Criteria
Inclusion
- previous poor response to ovarian stimulation in IVF.
Exclusion
- patients over the age of 42
- patients who received DHEA at any time.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
End Date :
July 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01145144
Start Date
January 1 2008
End Date
July 1 2009
Last Update
June 16 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical center IVF unit
Kfar Saba, Kfar Saba, Israel
2
Meir Medical Center
Kfar Saba, Kfar Sava, Israel